loading
Precedente Chiudi:
$0.3352
Aprire:
$0.3542
Volume 24 ore:
14.39M
Relative Volume:
13.85
Capitalizzazione di mercato:
$19.47M
Reddito:
-
Utile/perdita netta:
$-22.83M
Rapporto P/E:
-0.5127
EPS:
-0.79
Flusso di cassa netto:
$-20.87M
1 W Prestazione:
+24.81%
1M Prestazione:
+30.69%
6M Prestazione:
-46.36%
1 anno Prestazione:
-77.12%
Intervallo 1D:
Value
$0.3528
$0.4177
Intervallo di 1 settimana:
Value
$0.2933
$0.4177
Portata 52W:
Value
$0.2223
$2.535

Cognition Therapeutics Inc Stock (CGTX) Company Profile

Name
Nome
Cognition Therapeutics Inc
Name
Telefono
412-481-2210
Name
Indirizzo
2403 SIDNEY STREET, PITTSBURGH
Name
Dipendente
25
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-08
Name
Ultimi documenti SEC
Name
CGTX's Discussions on Twitter

Confronta CGTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CGTX
Cognition Therapeutics Inc
0.405 19.47M 0 -22.83M -20.87M -0.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-19 Aggiornamento B. Riley Securities Neutral → Buy
2024-07-30 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-11-03 Iniziato B. Riley Securities Buy
2021-11-03 Iniziato Oppenheimer Outperform

Cognition Therapeutics Inc Borsa (CGTX) Ultime notizie

pulisher
Jun 17, 2025

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 17, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Boosts Stock Position in Cognition Therapeutics, Inc. (NASDAQ:CGTX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Safety scares and trial misses drag down neuro biotechs into Q2 - BioWorld MedTech

Jun 13, 2025
pulisher
Jun 03, 2025

Cognition Therapeutics (CGTX) Secures Donation to Support Dement - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cognition Therapeutics Launches Expanded Access Program for Zervimesine - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Cognition Therapeutics Announces Expanded Access Program for Dementia with Lewy Bodies, Led by Dr. James Galvin - Nasdaq

Jun 03, 2025
pulisher
Jun 03, 2025

Philanthropic Donor Funds Cognition Therapeutics’ Expanded - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Major Breakthrough: Donor Funds New Treatment Access for Lewy Body Dementia Patients - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

B. Riley Expects Reduced Earnings for Cognition Therapeutics - Defense World

Jun 02, 2025
pulisher
May 30, 2025

HC Wainwright Issues Positive Forecast for CGTX Earnings - Defense World

May 30, 2025
pulisher
May 28, 2025

Alzheimer's Disease Pipeline 2025: MOA and ROA Insights, - openPR.com

May 28, 2025
pulisher
May 28, 2025

Cognition Therapeutics (NASDAQ:CGTX) Price Target Cut to $3.00 by Analysts at HC Wainwright - Defense World

May 28, 2025
pulisher
May 28, 2025

Cognition Therapeutics Releases New Episode of - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Lewy Body Dementia Caregivers Share Powerful Stories Alongside Leading Neurologists in New Medical Podcast - Stock Titan

May 28, 2025
pulisher
May 27, 2025

CGTX: HC Wainwright & Co. Lowers Price Target While Maintaining Buy Rating | CGTX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Cognition Therapeutics (CGTX) Sees Reduced Price Target Amid Exp - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Cognition Therapeutics (CGTX) Sees Reduced Price Target Amid Expected Equity Dilution | CGTX Stock News - GuruFocus

May 27, 2025
pulisher
May 23, 2025

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Average Recommendation of “Buy” from Brokerages - Defense World

May 23, 2025
pulisher
May 10, 2025

Chardan Capital Issues Pessimistic Forecast for Cognition Therapeutics (NASDAQ:CGTX) Stock Price - Defense World

May 10, 2025
pulisher
May 09, 2025

Cognition Therapeutics Presents Preclinical Data On Zervimesine, Stock Down - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Cognition announces outcomes from trial of zervimesine for geographic atrophy - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Cognition Therapeutics Inc (NASDAQ: CGTX) Stock Price Forecast: $100 - Stocksregister

May 09, 2025
pulisher
May 09, 2025

Cognition Therapeutics Reports Promising Preclinical Data for Zervimesine in Protecting RPE Cells from Dry AMD at ARVO 2025 - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Cognition Therapeutics Presented Data at Association for - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health - Stock Titan

May 09, 2025
pulisher
May 09, 2025

zervimesine shows promise in dry AMD trial - Investing.com

May 09, 2025
pulisher
May 09, 2025

Cognition Therapeutics Reports Q1 2025 Financials and Progress - TipRanks

May 09, 2025
pulisher
May 08, 2025

Oral zervimesine reduced GA lesion growth in phase 2 study from Cognition Therapeutics - Ophthalmology Times

May 08, 2025
pulisher
May 08, 2025

zervimesine shows promise in dry AMD trial By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Oral Zervimesine Reduces Geographic Atrophy Lesion Growth in Phase 2 Trial - HCPLive

May 08, 2025
pulisher
May 08, 2025

Cognition Therapeutics Announces Positive Phase 2 Trial Results - TipRanks

May 08, 2025
pulisher
May 08, 2025

Cognition Therapeutics Reports Topline Results Showing Oral Zervimesine (CT1812) Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy - Santé log

May 08, 2025
pulisher
May 08, 2025

Ratio Examination: Cognition Therapeutics Inc (CGTX)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 08, 2025
pulisher
May 08, 2025

Cognition Therapeutics Reports Topline Results Showing Oral - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Cognition Therapeutics, Inc. (CGTX) Reports Topline Results Showing Oral CT1812 Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy - StreetInsider

May 08, 2025
pulisher
May 08, 2025

Cognition Therapeutics, Inc. Reports Topline Results Showing Oral Zervimesine Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Cognition Therapeutics (CGTX) Stock Target Lowered by Chardan Ca - GuruFocus

May 08, 2025
pulisher
May 07, 2025

COGNITION THERAPEUTICS INC SEC 10-Q Report - TradingView

May 07, 2025
pulisher
May 07, 2025

Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update - The Manila Times

May 07, 2025
pulisher
May 07, 2025

Cognition Therapeutics, Inc. Advances Alzheimer’s and DLB Programs with FDA Meeting Request and Upcoming Presentations at AAIC and ARVO - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides ... - Bluefield Daily Telegraph

May 07, 2025
pulisher
May 07, 2025

Caregiver Distress The Hidden Burden Of Dementia With Lewy Bodies — And Why Measuring It Matters - Clinical Leader

May 07, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Raises Holdings in Cognition Therapeutics, Inc. (NASDAQ:CGTX) - Defense World

May 04, 2025
pulisher
Apr 28, 2025

CES ENERGY SOLUTIONS CORP. ANNOUNCES AMENDMENT AND EXTENSION TO ITS INCREASED CREDIT FACILITY - The Globe and Mail

Apr 28, 2025
pulisher
Apr 28, 2025

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Average Recommendation of “Buy” from Analysts - Defense World

Apr 28, 2025
pulisher
Apr 25, 2025

Cognition Therapeutics Inc [CGTX] Shares Fall Approximately -76.27% Over the Year - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Cognition Therapeutics Inc (CGTX) Stock: Navigating a Year of Volatility - investchronicle.com

Apr 25, 2025
pulisher
Apr 18, 2025

CGTX Stock Sees Surge of Approximately 16.59% in Last Five Days - knoxdaily.com

Apr 18, 2025
pulisher
Apr 11, 2025

Dry AMD Therapeutics Market Size in 7MM is expected to grow at - openPR.com

Apr 11, 2025
pulisher
Apr 09, 2025

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2024 Earnings Call Transcript - MSN

Apr 09, 2025
pulisher
Apr 08, 2025

Tscan Therapeutics Inc (TCRX) deserves deeper analysis - uspostnews.com

Apr 08, 2025

Cognition Therapeutics Inc Azioni (CGTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):